| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/14/2010 | US20100008967 Bioactive scaffolds |
| 01/14/2010 | US20100008955 Method and kit for detecting if an individual is susceptible to progress to an active mycobacterial disease |
| 01/14/2010 | US20100008954 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 01/14/2010 | US20100008953 Process for producing poxviruses and poxvirus compositions |
| 01/14/2010 | US20100008952 Vaccines for the Rapid Response to Pandemic Avian Influenza |
| 01/14/2010 | US20100008951 Flu vaccine admixture of mannan and flu antigen |
| 01/14/2010 | US20100008950 Composition and method for the induction of immunity against bacillus cereus group bacteria |
| 01/14/2010 | US20100008949 Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 01/14/2010 | US20100008948 Recombinant herpesvirus useful in vaccine production |
| 01/14/2010 | US20100008947 Porcine adenovirus e1 and e4 regions |
| 01/14/2010 | US20100008946 Microorganisms for therapy |
| 01/14/2010 | US20100008945 Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus |
| 01/14/2010 | US20100008944 Herpes simplex virus mutant and uses therefore |
| 01/14/2010 | US20100008943 Extracellular matrix-binding proteins from staphylococcus aureus |
| 01/14/2010 | US20100008942 Histophilus Somni Polynucleotides, Polypeptides and Methods of Use |
| 01/14/2010 | US20100008941 vaccination directed against the hepatitis C virus (HCV); |
| 01/14/2010 | US20100008940 Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| 01/14/2010 | US20100008939 Unprocessed rolling circle amplification product |
| 01/14/2010 | US20100008938 Self assembling amphiphilic polymers as antiviral agents |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008935 Method for identifying therapeutical targets in tumors, the use thereof and means for determining and targeting angiogenesis and hemostasis related to andenocarcinomas of the lung |
| 01/14/2010 | US20100008934 Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof |
| 01/14/2010 | US20100008933 Methods For Treating Obesity By Administering A TRKB Antagonist |
| 01/14/2010 | US20100008932 Use of soluble cd160 to suppress immunity |
| 01/14/2010 | US20100008931 Coronin 1 Modulators for the Treatment of Autoimmune and Lymphoproliferative Disorders and Mycobacterial Infections |
| 01/14/2010 | US20100008930 Method for the diagnosis of leukemia |
| 01/14/2010 | US20100008929 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 01/14/2010 | US20100008928 Agent for preventing/treating cancer |
| 01/14/2010 | US20100008927 Use of (S)-Roscovitine for Prevention and/or Treatment of Neurological Diseases |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008925 Methods and compositions for treatment of endotoxin-mediated pro-inflammatory responses |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008923 Organic Compounds |
| 01/14/2010 | US20100008922 In Vivo Induced Genes of Mycobacterium Tuberculosis |
| 01/14/2010 | US20100008921 Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative Diseases |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/14/2010 | US20100008919 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to inhibit angiogenesis that accompanies tumor development |
| 01/14/2010 | US20100008918 Methods for dosing an actriib antagonist and monitoring of treated patients |
| 01/14/2010 | US20100008917 Treatment of aplastic anemia |
| 01/14/2010 | US20100008916 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/14/2010 | US20100008915 Methods for treating disease using an anti-il-21 receptor antibody |
| 01/14/2010 | US20100008914 Methods and compositions for treating il-4 and il-13 related fibrosis related pathologies |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008912 Combination drug |
| 01/14/2010 | US20100008911 Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 01/14/2010 | US20100008910 Methods and compositions for the diagnosis and treatment of cancer |
| 01/14/2010 | US20100008909 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 01/14/2010 | US20100008908 Treatment of Heart Failure |
| 01/14/2010 | US20100008907 Muscle regeneration promoter |
| 01/14/2010 | US20100008906 Cripto binding molecules |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008904 administering to the subject an effective amount of an inhibitor of an acid-sensing ion channel 3, wherein the inhibitor is a polypeptide that binds to the acid-sensing ion channel 3 |
| 01/14/2010 | US20100008903 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 01/14/2010 | US20100008902 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof |
| 01/14/2010 | US20100008901 Methods for the treatment and prevention of cancer |
| 01/14/2010 | US20100008900 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 01/14/2010 | US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins |
| 01/14/2010 | US20100008888 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/14/2010 | US20100008858 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | US20100008852 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 01/14/2010 | US20100008851 Anti-gd2 antibodies and methods and uses related thereto |
| 01/14/2010 | CA2756053A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and antiviral, antibacterial, and anticancer agents |
| 01/14/2010 | CA2730473A1 Novel treatment |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730300A1 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | CA2730273A1 Nanotube-reinforced balloons for delivering therapeutic agents within or beyond the wall of blood vessels, and methods of making and using same |
| 01/14/2010 | CA2730268A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 01/14/2010 | CA2730201A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | CA2730185A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | CA2730178A1 Methods and compositions for enhanced delivery of macromolecules |
| 01/14/2010 | CA2730171A1 Soluble recombinant influenza antigens |
| 01/14/2010 | CA2730110A1 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2730073A1 Method of promoting neurogenesis |
| 01/14/2010 | CA2730048A1 Vaccine for the treatment of alzheimer's disease |
| 01/14/2010 | CA2729961A1 Compositions comprising antibodies to lingo or fragments thereof |
| 01/14/2010 | CA2729949A1 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 01/14/2010 | CA2729869A1 Therapeutic use of specific ligand in msrv associated diseases |
| 01/14/2010 | CA2729758A1 Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses |
| 01/14/2010 | CA2729633A1 Tumor-initiating cells and methods of use |
| 01/14/2010 | CA2729602A1 Notch1 receptor binding agents and methods of use thereof |
| 01/14/2010 | CA2729306A1 Notch-binding agents and antagonists and methods of use thereof |
| 01/14/2010 | CA2728909A1 Prostaglandin e2 binding proteins and uses thereof |
| 01/14/2010 | CA2728374A1 Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines |
| 01/14/2010 | CA2728347A1 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
| 01/14/2010 | CA2728341A1 Globo h and related anti-cancer vaccines with novel glycolipid adjuvants |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143735A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 01/13/2010 | EP2143730A2 Modified peptides and their use for the treatment of autoimmune diseases |
| 01/13/2010 | EP2143441A1 Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/13/2010 | EP2143440A1 Stabilising agent and vaccine composition comprising one or several attenuated living flavivirus |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2142931A1 Method for the diagnosis of tuberculosis |
| 01/13/2010 | EP2142660A2 Methods and systems for o-glycosylating proteins |